Alembic Pharma receives 4 observations from USFDA for Panelav facility

Alembic Pharma receives 4 observations from USFDA for Panelav facility "The US Food and Drug Administration (USFDA) has conducted an inspection at Alembic Pharmaceuticals general oral solid formulation facility located at Panelav from 9-13 March, 2020," the drug firm said in a filing to the BSE.

No comments:

Post a Comment